Patients with bronchiectasis from different European countries have strikingly different variations in microbiome composition and resistome.

Probiotics were favored over placebo for CDI prevention, particularly with twice-daily dosing, but their overall effect on disease incidence was not significant.

Alcohol use disorder (AUD) and alcohol consumption are associated with worse COVID-19 outcomes, according to study findings published in Chest.

After months with an appointed caretaker, the US Centers for Disease Control and Prevention finally has an official director.

This in-depth feature explores the challenges and controversies surrounding the diagnosis and management of PANDAS.

More than 1000 pounds of frozen ground beef are being recalled after metal pieces were reportedly found in the product.

Pregnant individuals commonly reported hesitancy toward RSVpreF and nirsevimab, indicating the need for efforts to promote the safety and uptake of RSV immunization.

The FDA is recommending that certain products containing 7-hydroxymitragynine be controlled under the Controlled Substances Act.

Janus kinase (JAK) inhibitors are associated with decreased mortality and fewer serious adverse events among adults hospitalized with COVID-19.

The FDA has approved a new prefilled syringe presentation of Shingrix (zoster vaccine recombinant, adjuvanted).

Cuts to Medicaid prompted by the One Big Beautiful Bill Act could lead to thousands of excess deaths each year.

Pemivibart was well tolerated and prophylactic against COVID-19 infection among adult patients with significant immunocompromising conditions.